PLERIXAFOR INJECTION
PLERIXAFOR INJECTION
Approved
DIN Number
02529815
Drug Class
Human
Market Date
Aug 31, 2023
Company
HC
Jamp Pharma Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02529815
AIG Number0153050001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L03AX16 PLERIXAFOR
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification20:16.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
PLERIXAFORActive
Strength: 20 MG / ML
Monograph: PLERIXAFOR